Nalagenetics
Singapore biotech firm Nalagenetics raises $12.6M Series A funding co-led by Intudo Ventures and Vulcan Capital
Nalagenetics announced Friday the closing of a $12.6 million Series A round of financing co-led by Intudo Ventures and Vulcan Capital. The round also saw participation from strategic investors, including Singapore-based Diagnostics Development Hub (DxD Hub) through the Agency for Science, Technology and Research’s (A*STAR) A*ccelerate Technologies Pte Ltd,…
